Sutro Biopharma (STRO) Non Operating Income (2024 - 2026)
Sutro Biopharma (STRO) posted Non Operating Income of -$8.8 million for Q4 2025, down 4.73% sequentially from -$8.4 million in Q3 2025, and down 82.09% YoY from -$49.1 million in Q4 2024.
Powered by 
Analysis
Sutro Biopharma (STRO) Non Operating Income (2024 - 2026) Analysis & Trends
Sutro Biopharma has reported Non Operating Income for 2 years, with the latest figure at -$8.8 million in Q4 2025.
- Quarterly Non Operating Income fell 82.09% year-over-year to -$8.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$32.8 million (down 345.74% YoY) and the FY2025 annual result came in at -$32.8 million, down 345.69% from the prior year.
- Non Operating Income eased to -$8.8 million in Q4 2025 per STRO's latest filing, from -$8.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $19.1 million in Q3 2024 and troughed at -$8.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Sutro Biopharma | 333.09 Mn | 168.74 Mn | - | -8.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.64 Mn |
| Dec 31, 2025 | -8.80 Mn |
| Sep 30, 2025 | -8.40 Mn |
| Jun 30, 2025 | -8.17 Mn |
| Mar 31, 2025 | -7.45 Mn |
| Dec 31, 2024 | -4.83 Mn |
| Sep 30, 2024 | 19.13 Mn |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | -1.62 Mn |